[1] 王锡山. 中美结直肠癌流行病学特征对比及防控策略分析[J]. 中华结直肠疾病电子杂志, 2019, 8(1):7-11. [2] 郭天安, 谢丽, 赵江, 等. 中国结直肠癌1988—2009年发病率和死亡率趋势分析[J]. 中华胃肠外科杂志, 2018,21(1):33-40. [3] Laissue P.The forkhead-box family of transcription factors: Key molecular players in colorectal cancer pathogenesis[J]. Mol Cancer, 2019, 18(1): 1-13. [4] 梁大艳,林绍良,陈剑雄,等.2014—2016年肇庆市端州区恶性肿瘤发病与死亡分析[J].华南预防医学,2021,47(8):968-971. [5] 李超,王琳.郑州市25 986例消化道肿瘤病例疾病谱分析[J].华南预防医学,2021,47(7):889-891. [6] Zhang H, Chang Y, Zheng Q, et al.Altered intestinal microbiota associated with colorectal cancer[J]. Front Med, 2019, 13(4): 461-470. [7] 樊逸夫,白晓敏,杜娟.肠道菌群对肿瘤影响的研究进展[J].癌症进展,2019,17(15):1741-1744. [8] Seesaha PK, Chen X, Wu X, et al.The interplay between dietary factors, gut microbiome and colorectal cancer: A new era of colorectal cancer prevention[J]. Future Oncol, 2020, 16(7): 293-306. [9] 索明果,范筱,李英宽,等.肠道腺瘤性息肉和结直肠癌患者肠道菌群变化及其差异[J].河南医学研究,2020,29(18):3302-3303. [10] Rawla P, Sunkara T, Barsouk A.Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors[J]. Przeglad gastroenterologiczny, 2019, 14(2): 89. [11] Araghi M, Soerjomataram I, Bardot A, et al.Changes in colorectal cancer incidence in seven high-income countries: A population-based study[J]. Lancet Gastroenterol Hepatol, 2019, 4(7): 511-518. [12] White A, Ironmonger L, Steele RJC, et al.A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK[J]. BMC Cancer, 2018, 18(1): 1-11. [13] 张英丽,陈倩倩,刘颖.微生态制剂在早期结直肠癌根治术后的作用[J].中国微生态学杂志,2020,32(10):1167-1172. [14] Gursoy S, Koçkar T, Atik SU, et al.Autoimmunity and intestinal colonization by Candida albicans in patients with type 1 diabetes at the time of the diagnosis[J]. Korean J Pediatr, 2018, 61(7): 217. [15] Yue T, Lu HY, Xue ZY, et al.Structural features of intestinal flora in preterm rats with cognitive impairment: An analysis based on high-thorough sequencing[J]. Chin J Contemp Pediatr, 2019, 21(7): 701-707. [16] Ibrahim A, Hugerth LW, Hases L, et al.Colitis‐induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity[J]. Int J Cancer, 2019, 144(12): 3086-3098. [17] 夏周琦, 庚天琦, 李霞,等. 肠道菌群与结直肠癌的关系[J]. 国际遗传学杂志, 2021, 44(4):238-245. [18] Yamaoka Y, Suehiro Y, Hashimoto S, et al.Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population[J]. J Gastroenterol, 2018, 53(4): 517-524. [19] Yamamoto S, Kinugasa H, Hirai M, et al.Heterogeneous distribution of Fusobacterium nucleatum in the progression of colorectal cancer[J]. J Gastroenterol Hepatol, 2021, 36(7): 1869-1876. [20] Datorre JG, de Carvalho AC, Guimaraes DP, et al. The role of Fusobacterium nucleatum in colorectal carcinogenesis[J]. Pathobiology, 2021, 88(2): 127-140. [21] Pleguezuelos-Manzano C, Puschhof J, Huber AR, et al.Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli[J]. Nature, 2020, 580(7802): 269-273. [22] Thakur BK, Malaisé Y, Martin A.Unveiling the mutational mechanism of the bacterial genotoxin colibactin in colorectal cancer[J]. Molecular cell, 2019, 74(2): 227-229. [23] Lopes A, Billard E, Casse AH, et al.Colibactin-positive Escherichia coli induce a procarcinogenic immune environment leading to immunotherapy resistance in colorectal cancer[J]. Int J cancer, 2020, 146(11): 3147-3159. [24] Haghi F, Goli E, Mirzaei B, et al.The association between fecal Enterotoxigenic B. fragilis with colorectal cancer[J]. BMC Cancer, 2019, 19(1): 1-4. [25] 黄奔,范维,王萍,等.肿瘤坏死因子α在恶性肿瘤诊疗中的研究进展[J].分子诊断与治疗杂志,2021,13(9):1377-1380. |